Ana Tovar

820 total citations
33 papers, 576 citations indexed

About

Ana Tovar is a scholar working on Cell Biology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Ana Tovar has authored 33 papers receiving a total of 576 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cell Biology, 14 papers in Surgery and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Ana Tovar's work include Proteoglycans and glycosaminoglycans research (15 papers), Heparin-Induced Thrombocytopenia and Thrombosis (7 papers) and Venous Thromboembolism Diagnosis and Management (7 papers). Ana Tovar is often cited by papers focused on Proteoglycans and glycosaminoglycans research (15 papers), Heparin-Induced Thrombocytopenia and Thrombosis (7 papers) and Venous Thromboembolism Diagnosis and Management (7 papers). Ana Tovar collaborates with scholars based in Brazil, Israel and Netherlands. Ana Tovar's co-authors include Paulo A.S. Mourão, Gustavo Ramalho Cardoso dos Santos, M. S. Pereira, Eduardo Vilanova, Yair Molad, Bianca F. Glauser, Mariana P. Stelling, Roberto J. C. Fonseca, Vitor H. Pomin and Eytan Mor and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Ana Tovar

31 papers receiving 560 citations

Peers

Countries citing papers authored by Ana Tovar

Since Specialization

Citations

This map shows the geographic impact of Ana Tovar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Tovar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Tovar more than expected).

Fields of papers citing papers by Ana Tovar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Tovar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Tovar. The network helps show where Ana Tovar may publish in the future.

Co-authorship network of co-authors of Ana Tovar

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Tovar. A scholar is included among the top collaborators of Ana Tovar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Tovar. Ana Tovar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Israel’s First Port-Based Hepatic Artery Infusion Program: Early Outcomes in Colorectal Liver Metastases 2025 ·Annals of Surgical Oncology ·(unknown), (unknown), (unknown), (unknown), Yael Berger, (unknown), (unknown), (unknown), Ana Tovar, Baruch Brenner, Nir Wasserberg, Eran Sadot	0
2	Approaches to Assure Similarity between Pharmaceutical Heparins from Two Different Manufacturers 2023 ·Pharmaceutics ·(unknown), (unknown), (unknown), (unknown), (unknown), Eduardo Vilanova, Ana Tovar, Paulo A.S. Mourão	6
3	Neutrophil-to-Lymphocyte Ratio Predicts Recurrence Pattern in Patients with Resectable Colorectal Liver Metastases 2021 ·Annals of Surgical Oncology ·(unknown), Yael Berger, (unknown), (unknown), Ana Tovar, Sara Morgenstern, Baruch Brenner, Daniel Benchimol, Hanoch Kashtan, Eran Sadot	18
4	Sarcopenia as a Predictor of Survival in Patients with Pancreatic Adenocarcinoma After Pancreatectomy 2021 ·Annals of Surgical Oncology ·(unknown), (unknown), Jeroen L.A. van Vugt, Yael Berger, (unknown), Sara Morgenstern, Ana Tovar, Baruch Brenner, Daniel Benchimol, Hanoch Kashtan, Eran Sadot	24
5	Heparins Sourced From Bovine and Porcine Mucosa Gain Exclusive Monographs in the Brazilian Pharmacopeia 2019 ·Frontiers in Medicine ·Eduardo Vilanova, (unknown), (unknown), Bianca F. Glauser, (unknown), Gustavo Ramalho Cardoso dos Santos, Ana Tovar, M. S. Pereira, Paulo A.S. Mourão	15
6	A Rare Case of Takotsubo Syndrome in a Patient 5 Months After Heart Transplantation 2019 ·ESC Heart Failure ·Osnat Itzhaki Ben Zadok, (unknown), Ashraf Hamdan, Ana Tovar, Alexander R. Lyon, Tuvia Ben Gal	4
7	Chemical and pharmacological aspects of neutralization of heparins from different animal sources by protamine 2018 ·Journal of Thrombosis and Haemostasis ·Bianca F. Glauser, Gustavo Ramalho Cardoso dos Santos, (unknown), Ana Tovar, M. S. Pereira, Eduardo Vilanova, Paulo A.S. Mourão	8
8	Structural and haemostatic features of pharmaceutical heparins from different animal sources: challenges to define thresholds separating distinct drugs 2016 ·Scientific Reports ·Ana Tovar, Gustavo Ramalho Cardoso dos Santos, (unknown), (unknown), Bianca F. Glauser, M. S. Pereira, Eduardo Vilanova, Paulo A.S. Mourão	30
9	Association of Low Serum Complement C3 with Reduced Patient and Renal Survival in Antimyeloperoxidase-Associated Small-Vessel Vasculitis 2014 ·Nephron Clinical Practice ·Yair Molad, Ana Tovar, (unknown)	35
10	Structural and functional analyses of bovine and porcine intestinal heparins confirm they are different drugs 2014 ·Drug Discovery Today ·Gustavo Ramalho Cardoso dos Santos, Ana Tovar, (unknown), M. S. Pereira, Vitor H. Pomin, Paulo A.S. Mourão	33
11	Effect of castration on renal glycosaminoglycans and their urinary excretion in male and female rats with chronic renal failure 2013 ·Brazilian Journal of Medical and Biological Research ·(unknown), Ana Tovar, (unknown), Rachel Bregman	6
12	Bovine and porcine heparins: different drugs with similar effects on human haemodialysis 2013 ·BMC Research Notes ·Ana Tovar, (unknown), (unknown), Maurilo Leite, Jocemir Ronaldo Lugon, Paulo A.S. Mourão	22
13	Matrix-bound heparan sulfate is essential for the growth and pluripotency of human embryonic stem cells 2012 ·Glycobiology ·Mariana P. Stelling, (unknown), Ana Tovar, Paulo A.S. Mourão, Stevens K. Rehen	12
14	Heparin from bovine intestinal mucosa: Glycans with multiple sulfation patterns and anticoagulant effects 2012 ·Thrombosis and Haemostasis ·Ana Tovar, (unknown), Gustavo Ramalho Cardoso dos Santos, (unknown), (unknown), Roberto J. C. Fonseca, P. A. S. Mourão	29
15	The dermatan sulfate-dependent anticoagulant pathway is mostly preserved in aneurysm and in severe atherosclerotic lesions while the heparan sulfate pathway is disrupted 2011 ·Clinica Chimica Acta ·Ana Tovar, (unknown), (unknown), (unknown), (unknown), Paulo A.S. Mourão	5
16	Adenocarcinoma Within a Paracoccygeal Teratoma in an Adult: Report of a Case 2005 ·Surgery Today ·(unknown), Ana Tovar, Haim Gutman	4
17	Dermatan sulfate is the predominant antithrombotic glycosaminoglycan in vessel walls: Implications for a possible physiological function of heparin cofactor II 2005 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Ana Tovar, (unknown), Mariana P. Stelling, (unknown), (unknown), Paulo A.S. Mourão	53
18	Human venous and arterial glycosaminoglycans have similar affinity for plasma low-density lipoproteins 2002 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·(unknown), Paulo A.S. Mourão, Ana Tovar	35
19	Mucormycosis of the renal allograft: case report and review of the literature 2001 ·Transplant International ·Archil Chkhotua, (unknown), Ana Tovar, Miriam Weinberger, (unknown), N Bar-Nathan, E Shaharabani, (unknown), Eytan Mor	43
20	Age-Related Changes in Populations of Aortic Glycosaminoglycans 1998 ·Arteriosclerosis Thrombosis and Vascular Biology ·Ana Tovar, (unknown), (unknown), Paulo A.S. Mourão	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact